manufacturing defects – Page 22 – Pharma.Tips

Delivered dose uniformity failure during stability testing – device vs formulation investigation

Investigating Delivered Dose Uniformity Failures During Stability Testing in Pharmaceutical Manufacturing In pharmaceutical manufacturing, particularly in the production of dry powder inhalers (DPIs), maintaining product quality and consistency is paramount.…

Capsule puncture failure during inspection readiness – CAPA control strategy gap

Addressing Capsule Puncture Failures During Inspection Readiness: A Comprehensive Investigation Capsule puncture failures present significant challenges in pharmaceutical manufacturing, particularly in the dry powder inhaler (DPI) sector. These failures can…

Powder flow issue during inspection readiness – device vs formulation investigation

Addressing Powder Flow Challenges During Inspection Readiness: A Comprehensive Investigation Framework Powder flow issues during the inspection readiness phase can pose significant challenges within pharmaceutical manufacturing, particularly for products such…

Capsule puncture failure during DPI filling – regulatory expectation mismatch

Understanding Capsule Puncture Failures During DPI Filling and Regulatory Expectations In the competitive landscape of pharmaceutical manufacturing, ensuring the integrity of drug delivery systems is essential. One critical issue is…

Powder flow issue during inspection readiness – CAPA control strategy gap

Addressing Powder Flow Issues During Inspection Readiness: A Comprehensive Investigation Approach In the pharmaceutical manufacturing landscape, the detection of a powder flow issue during inspection readiness can pose significant risks,…

Powder flow issue during DPI filling – CAPA control strategy gap

Addressing Powder Flow Challenges in DPI Filling: A Comprehensive Investigation Dry powder inhalers (DPIs) are critical in delivering medication effectively, yet they can present substantial manufacturing challenges, notably powder flow…

Sedimentation rate failure during bulk preparation – regulatory inspection risk

Understanding Sedimentation Rate Failures During Bulk Preparation: A Guide to Investigation and Compliance In pharmaceutical manufacturing, sedimentation rate failure during bulk preparation poses significant risks not only to product quality…

Viscosity variation during storage – root cause and preventive controls

Understanding Viscosity Variation During Storage: Root Cause Investigation and Preventive Control Measures Viscosity variation during storage is a common yet critical issue in the pharmaceutical manufacturing of liquid formulations, particularly…

Preservative failure during filling – root cause and preventive controls

Understanding Preservative Failure During Filling: A Root Cause Investigation Preservative failure during filling can pose significant risks to both product integrity and patient safety. This issue often results in deviations…

Sedimentation rate failure during filling – QA investigation failure

QA Investigation of Sedimentation Rate Failures in Filling Processes Sedimentation rate failures during the filling process can significantly impact product quality and regulatory compliance. Such occurrences might lead to deviations…

Phase separation during filling – root cause and preventive controls

Investigating Phase Separation During Filling: Root Cause and Preventive Measures Phase separation during filling is a critical concern in pharmaceutical manufacturing, particularly for formulations like suspensions and syrups. Such events…

Viscosity variation during storage – regulatory inspection risk

Understanding Viscosity Variation During Storage: Ensuring Inspection Readiness Viscosity variation in pharmaceutical products during storage can lead to significant quality issues and regulatory inspection risks. In a scenario where a…